Does preoperative chemotherapy cause adverse effects on the perioperative course of patients undergoing esophagectomy for carcinoma?
- 1 May 1999
- journal article
- clinical trial
- Published by Springer Science and Business Media LLC in The Japanese Journal of Thoracic and Cardiovascular Surgery
- Vol. 47 (5), 199-203
- https://doi.org/10.1007/bf03217994
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- First-Line Chemotherapy Improves the Resection Rate and Long-Term Survival of Locally Advanced (T4, any N, M0) Squamous Cell Carcinoma of the Thoracic EsophagusAnnals of Surgery, 1997
- Chemoradiotherapy Followed by Surgery Compared with Surgery Alone in Squamous-Cell Cancer of the EsophagusNew England Journal of Medicine, 1997
- Induction Chemoradiotherapy Followed by Esophagectomy in Patients With Carcinoma of the EsophagusThe Annals of Thoracic Surgery, 1997
- The Role of Neoadjuvant Therapy in Surgically Resectable Esophageal CancerArchives of Surgery, 1996
- Randomized Trial of Preoperative Chemotherapy for Squamous Cell Cancer of the EsophagusArchives of Surgery, 1992
- American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis.1992
- American College of Chest Physicians/Society of Critical Care Medicine Consensus ConferenceCritical Care Medicine, 1992